Z. Xiang

发表

A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53.

R. Hoffmann, H. Deng, L. Otvos, 1998, Biochimica et biophysica acta.

A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge.

Z. Xiang, H. Ertl, M. Lasaro, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis

Z. Xiang, H. Ertl, A. Hill, 2018, bioRxiv.

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

Z. Xiang, H. Ertl, Jun Cheng, 1994, Virology.

Protection of non-human primates against rabies with an adenovirus recombinant vaccine.

C. Rupprecht, Z. Xiang, H. Ertl, 2014, Virology.

Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.

D. Tang, Z. Xiang, H. Ertl, 2002, Veterinary Microbiology.

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

Z. Xiang, H. Ertl, J. Wilson, 1996, Virology.

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

Z. Xiang, H. Ertl, J. Wilson, 2003, Journal of Virology.

The effect of rapamycin and ibrutinib on antibody responses to adeno-associated virus vector-mediated gene transfer.

Z. Xiang, H. Ertl, Xiangyang Zhou, 2022, Human gene therapy.

Comparison of the effects of amino acid substitutions and beta-N- vs. alpha-O-glycosylation on the T-cell stimulatory activity and conformation of an epitope on the rabies virus glycoprotein.

L. Otvos, Z. Xiang, H. Ertl, 1995, Biochimica et biophysica acta.

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.

Z. Xiang, H. Ertl, J. Wilson, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Glycosylation of synthetic T helper cell epitopic peptides influences their antigenic potency and conformation in a sugar location-specific manner.

L. Otvos, Z. Xiang, H. Ertl, 1994, Biochimica et biophysica acta.

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens

M. Betts, Z. Xiang, H. Ertl, 2009, The Journal of Immunology.

Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus Vectors

N. Letvin, S. Hensley, Z. Xiang, 2007, Journal of Virology.

Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.

Z. Xiang, H. Ertl, S. Pasquini, 1999, Journal of immunology.

Location-specific influence of incorporated carbohydrate side chains on the conformation and antigenic potency of an immunodominant synthetic T helper cell epitope

L. Otvos, Z. Xiang, H. Ertl, 1995 .

Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes

Z. Xiang, H. Ertl, J. Wilson, 2004, Journal of Virology.

Cytokines and costimulatory molecules as genetic adjuvants

H. Deng, Z. Xiang, M. Blaszczyk-Thurin, 1997, Immunology and cell biology.

Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product

Z. Xiang, H. Ertl, James M. Wilson, 2002, Journal of Virology.

Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.

Z. Xiang, H. Ertl, Dongming Zhou, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines.

L. Otvos, Z. Xiang, H. Ertl, 1996, Vaccine.

A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer.

Z. Xiang, H. Ertl, Dongming Zhou, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals

L. Montaner, R. Gross, Z. Xiang, 2012, AIDS.

A method that allows easy characterization of tumor-infiltrating lymphocytes.

Z. Xiang, M. Blaszczyk-Thurin, H. Ertl, 2001, Journal of immunological methods.

Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma

Z. Xiang, H. Ertl, R. Kurupati, 2018, Cancer Immunology, Immunotherapy.

A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag 1

Z. Xiang, H. Ertl, James M. Wilson, 2003, The Journal of Immunology.

B cell responses to the 2011/12-influenza vaccine in the aged

Susan A. Doyle, K. Schmader, Z. Xiang, 2013, Aging.

Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.

B. Williams, R. Silverman, S. Hensley, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.

Z. Xiang, H. Ertl, Hildegund C. J. Ertl, 1995, Immunity.

Novel vaccine approaches.

Z. Xiang, H. Ertl, 1996, Journal of Immunology.

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.

Z. Xiang, H. Ertl, M. Lasaro, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Immune response to neonatal genetic immunization.

Z. Xiang, H. Ertl, S. Pasquini, 1997, Virology.

Vaccine Design: Replication-Defective Adenovirus Vectors.

Z. Xiang, H. Ertl, Xiangyang Zhou, 2016, Methods in molecular biology.

A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.

S. Hensley, Z. Xiang, H. Ertl, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa

S. Ellenberg, M. Kalish, Z. Xiang, 2006, Emerging infectious diseases.

Recombinant Vaccine to HIV-1 Gag A Simian Replication-Defective Adenoviral

Z. Xiang, H. Ertl, G. Pavlakis, 2013 .

Immune responses to nucleic acid vaccines to rabies virus.

Z. Xiang, H. Ertl, Jun Cheng, 1995, Virology.

The effects of post-translational side-chain modifications on the stimulatory activity, serum stability and conformation of synthetic peptides carrying T helper cell epitopes.

L. Otvos, J. Wade, Z. Xiang, 1996, Biochimica et biophysica acta.

Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys.

Z. Xiang, H. Ertl, M. I. Hernández, 2010, Virology.

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.

Z. Xiang, H. Ertl, D. Kowalczyk, 2000, Virology.

A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.

Z. Xiang, H. Ertl, Dongming Zhou, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Effect of Passive Immunization or Maternally Transferred Immunity on the Antibody Response to a Genetic Vaccine to Rabies Virus

Z. Xiang, H. Ertl, S. Pasquini, 1998, Journal of Virology.

Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis

C. Rupprecht, Z. Xiang, H. Ertl, 2018, Veterinary sciences.

Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice 1

Z. Xiang, H. Ertl, James M. Wilson, 2003, The Journal of Immunology.

Neonatal Mice Product-Specific Antibody Responses in Vaccine Carriers Induce Transgene Mucosally Delivered E1-Deleted Adenoviral

Z. Xiang, H. Ertl, James M. Wilson, 2003 .

Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.

Z. Xiang, H. Ertl, James M. Wilson, 2002, The Journal of general virology.

Replication-Defective Vector Based on a Chimpanzee Adenovirus

R. M. Burnett, Z. Xiang, H. Ertl, 2001, Journal of Virology.

Prime-boost vaccinations with two serologically distinct chimpanzee adenovirus vectors expressing SARS-CoV-2 spike or nucleocapsid tested in a hamster COVID-19 model

Xiaoping Zhou, Z. Xiang, H. Ertl, 2022, bioRxiv.

Pre-clinical testing of two serologically distinct chimpanzee-origin adenovirus vectors expressing spike of SARS-CoV-2

Z. Xiang, H. Ertl, W. Giles-Davis, 2022, bioRxiv.

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.

Z. Xiang, H. Ertl, Z. Fu, 2000, Vaccine.

Immune effector mechanisms required for protection to rabies virus.

Z. Xiang, H. Ertl, B. Knowles, 1995, Virology.

Stable secretion of a soluble, oligomeric form of rabies virus glycoprotein: influence of N-glycan processing on secretion.

R. Doms, Z. Xiang, H. Ertl, 1995, Biochemistry.

Adenoviral Recombinant Immunization with a Replication-Defective Priming and Intranasal Booster Induction of Genital Immunity by DNA

Z. Xiang, H. Ertl, S. Pasquini, 1999 .

Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens1

M. Betts, Z. Xiang, H. Ertl, 2009, The Journal of Immunology.

Induction of mucosal immunity with a replication-defective adenoviral recombinant.

Z. Xiang, H. Ertl, 1999, Vaccine.

A simple method to test the ability of individual viral proteins to induce immune responses.

Z. Xiang, H. Ertl, 1994, Journal of virological methods.

Next generation of rabies vaccines

Z. Xiang, H. Ertl, 2020, Rabies.

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

Z. Xiang, H. Ertl, James M. Wilson, 2005, Journal of Virology.

The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus

Z. Xiang, H. Ertl, S. Pasquini, 1997, Journal of virology.

Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

P. Kaleebu, B. Jia, M. Betts, 2010, Journal of Virology.

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

E. Wherry, S. Hensley, Z. Xiang, 2007, Blood.

Plasmid Vectors as Anti‐Viral Vaccines a

Z. Xiang, H. Ertl, Z. He, 1995, Annals of the New York Academy of Sciences.

The Effect of CpG Sequences on Capsid-Specific CD8+ T Cell Responses to AAV Vector Gene Transfer.

Z. Xiang, H. Ertl, R. Kurupati, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.

Z. Xiang, H. Ertl, K. Ewer, 2022, The Lancet. Microbe.

Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques.

J. Brenchley, M. Betts, Z. Xiang, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Susan A. Doyle, K. Schmader, Z. Xiang, 2016, Oncotarget.

An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector

Z. Xiang, H. Ertl, Dongming Zhou, 2010, Nature Protocols.

The fourth author's name was omitted from the article. The corrected author and affiliation lines are shown below.

M. Betts, Z. Xiang, H. Ertl, 2009 .

Erratum: Rupprecht, C.E., et al. Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis. Vet. Sci. 2018, 5, 59

Charles E Rupprecht, Zhiquan Xiang, Alexandre Servat, 2018, Veterinary sciences.

Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19

Xiaoping Zhou, Z. Xiang, H. Ertl, 2022, Microbes and Infection.

Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection

Z. Xiang, H. Ertl, Mohadeseh Hasanpourghadi, 2021, Virology journal.

Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors

J. Billingsley, Z. Xiang, H. Ertl, 2018, EBioMedicine.

A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.

Z. Xiang, H. Ertl, R. Kurupati, 2016, Human gene therapy methods.

Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.

Z. Xiang, H. Ertl, R. Kurupati, 2014, Human gene therapy.

Genetic vaccines — a revolution in vaccinology?

H. Deng, Z. Xiang, M. Blaszczyk-Thurin, 2004, Springer Seminars in Immunopathology.

T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cells.

Z. Xiang, H. Ertl, J. Wilson, 2003, Virology.

The effect of interferon-γ on genetic immunization

Z. Xiang, H. Ertl, Zhenning He, 1997 .

implications for their use as vaccines Adenoviral vectors persist in vivo and maintain activated CD8+ T cells:

E. Wherry, S. Hensley, Z. Xiang, 2013 .

Transfer of maternal antibodies results in inhibition of specific immune responses in the offspring.

Z. Xiang, H. Ertl, 1992, Virus research.

Phosphopeptide models of the C-terminal basic domain of p53

L. Otvos, Z. Xiang, M. Blaszczyk-Thurin, 2002 .